Angharad de Cates reviews a recent Danish trial, which finds that escitalopram reduced participants’ reinforcement sensitivity compared to those on placebo. This lower reinforcement sensitivity may be similar to the emotional blunting effect often reported by patients during SSRI treatment.
[read the full story...]
Andie Ashdown and Theophanis Kyriacou summarise a systematic review on virtual reality-based assessment and treatment of social functioning impairments in psychosis.
[read the full story...]
Joe Barnby considers the findings of a recent meta-analysis of cross-sectional observational data, which explores the association of cannabis with cognitive functioning in adolescents and young adults.
[read the full story...]
Mike Clark considers two recent systematic reviews of assistive technology to support people living with dementia.
[read the full story...]
Becci Strawbridge explores a prospective cohort study that looks at variation in the recall of socially rewarding information and depressive symptom severity.
[read the full story...]
Elizabeth Collier writes her debut blog on the REMCARE randomised controlled trial of reminiscence groups for people with dementia and their family carers.
[read the full story...]
Raluca Lucacel summarises a systematic review of individually modifiable risk factors to ameliorate cognitive ageing. The study included Mediterranean diet, Tai Chi, Soy isoflavones, B Vitamins and Vitamin D.
[read the full story...]
Kirsten Lawson reviews a randomised controlled trial looking at the impact of providing clinician photos on inpatient’s recall of names and roles. Is this an effective way to improve communication between inpatients and their care team?
[read the full story...]
Last week the media reported widely on a study of ketamine for depression (McShane et al, 2014). As usual the headlines made bold assertions, the Telegraph running with “Horse tranquilliser Ketamine could cure severe depression” (Knapton, 2014). But what did the paper authored by an Oxford group and published in the Journal of Psychopharmacology really [read the full story…]
